Cargando…

Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

Tyrosine-specific protein kinase (TPK) has been associated with the cytoplasmic domain of growth factor receptors as well as oncoproteins. Enzymatic activation appears to be a major initial event in these signal transduction pathways. In this study, TPK was determined in the cytosols of 249 node-pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Romain, S., Chinot, O., Klijn, J. G., van Putten, W. L., Guirou, O., Look, M., Martin, P. M., Foekens, J. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033501/
https://www.ncbi.nlm.nih.gov/pubmed/8054279
_version_ 1782136851204669440
author Romain, S.
Chinot, O.
Klijn, J. G.
van Putten, W. L.
Guirou, O.
Look, M.
Martin, P. M.
Foekens, J. A.
author_facet Romain, S.
Chinot, O.
Klijn, J. G.
van Putten, W. L.
Guirou, O.
Look, M.
Martin, P. M.
Foekens, J. A.
author_sort Romain, S.
collection PubMed
description Tyrosine-specific protein kinase (TPK) has been associated with the cytoplasmic domain of growth factor receptors as well as oncoproteins. Enzymatic activation appears to be a major initial event in these signal transduction pathways. In this study, TPK was determined in the cytosols of 249 node-positive primary breast tumours. Enzyme activity was measured using [32P]ATP and poly(glutamic acid-tyrosine) (4:1) as an artificial substrate. Levels of TPK varied from 0 to 35.9 pmol ATP min-1 mg-1 protein (median 11.4). No correlation was found with tumour size or number of positive lymph nodes. In contrast, levels of TPK were negatively associated with age (P = 0.01) and menopausal status (P < 0.05) of the patients. Higher concentrations of TPK were in addition found in tumours negative for oestradiol (P < 0.01) and progesterone (P < 0.05) receptors. Finally, a positive correlation was found between TPK and urokinase plasminogen activator (UPA) (P < 0.05). Patients whose tumours contained high levels of TPK had reduced disease-free (P = 0.01) and overall survival (P < 0.05). In Cox multivariate analysis, including patient's age, menopausal status, tumour size, number of positive lymph nodes, steroid receptors and UPA, TPK retained its independent prognostic importance.
format Text
id pubmed-2033501
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20335012009-09-10 Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients. Romain, S. Chinot, O. Klijn, J. G. van Putten, W. L. Guirou, O. Look, M. Martin, P. M. Foekens, J. A. Br J Cancer Research Article Tyrosine-specific protein kinase (TPK) has been associated with the cytoplasmic domain of growth factor receptors as well as oncoproteins. Enzymatic activation appears to be a major initial event in these signal transduction pathways. In this study, TPK was determined in the cytosols of 249 node-positive primary breast tumours. Enzyme activity was measured using [32P]ATP and poly(glutamic acid-tyrosine) (4:1) as an artificial substrate. Levels of TPK varied from 0 to 35.9 pmol ATP min-1 mg-1 protein (median 11.4). No correlation was found with tumour size or number of positive lymph nodes. In contrast, levels of TPK were negatively associated with age (P = 0.01) and menopausal status (P < 0.05) of the patients. Higher concentrations of TPK were in addition found in tumours negative for oestradiol (P < 0.01) and progesterone (P < 0.05) receptors. Finally, a positive correlation was found between TPK and urokinase plasminogen activator (UPA) (P < 0.05). Patients whose tumours contained high levels of TPK had reduced disease-free (P = 0.01) and overall survival (P < 0.05). In Cox multivariate analysis, including patient's age, menopausal status, tumour size, number of positive lymph nodes, steroid receptors and UPA, TPK retained its independent prognostic importance. Nature Publishing Group 1994-08 /pmc/articles/PMC2033501/ /pubmed/8054279 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Romain, S.
Chinot, O.
Klijn, J. G.
van Putten, W. L.
Guirou, O.
Look, M.
Martin, P. M.
Foekens, J. A.
Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
title Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
title_full Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
title_fullStr Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
title_full_unstemmed Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
title_short Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
title_sort prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033501/
https://www.ncbi.nlm.nih.gov/pubmed/8054279
work_keys_str_mv AT romains prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT chinoto prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT klijnjg prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT vanputtenwl prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT guirouo prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT lookm prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT martinpm prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients
AT foekensja prognosticvalueofcytosolictyrosinekinaseactivityin249nodepositivebreastcancerpatients